Kai Markus Schneider

Prof. Kai Markus Schneider is a Full Professor of Molecular Gastroenterology and Hepatology at Dresden University of Technology, where he leads the Experimental Gastroenterology and Organ Crosstalk research group at the Center for Regenerative Therapies Dresden (CRTD) and Else Kröner Fresenius Center for Digital Health. He also serves as a Senior Physician in the Department of Medicine I at University Hospital Dresden.

His research focuses on understanding the molecular circuitry of cellular and inter-organ communication, particularly the interactions between the gut, microbiome, liver, and nervous system. Using advanced techniques like functional genomics, metabolomics, and computational biology, his lab investigates how neuroimmune signals drive chronic inflammation and how organ systems interact in disease processes. Key discoveries include identifying a molecular mechanism by which psychological stress amplifies inflammatory responses in IBD and discovering a novel glial cell population that promotes inflammation.

Prof. Schneider's publication record demonstrates strong momentum with recent papers in Cell (2023), Nature Communications (2021-2023), and Nature Metabolism (2021), focusing on microbiota modulation, neuro-immune interactions, and liver disease mechanisms. His work bridges basic science with clinical applications through analysis of large patient cohorts including UK Biobank and Penn Medicine Biobank.

Scientific Recognition

• Publications in top-tier journals including Cell, Nature Communications, and Nature Metabolism
• Research funded by European and German institutions
• Leadership of interdisciplinary research group at CRTD

Prof. Schneider actively mentors students and researchers, with current team members including postdocs, predocs, technicians, and international students. His lab utilizes state-of-the-art methodologies including single-cell and spatial transcriptomics, microbiome analyses, confocal microscopy, and advanced computational approaches to study complex disease mechanisms. The lab maintains strong connections between basic research and clinical translation, applying findings from experimental models to human disease contexts.